Launch of Coalition Next to promote innovation in health

[ad_1]

Emanation of the Health Innovation Coalition – Health Crisis launched in 2020, Coalition Next aims to meet the unmet needs of patients, healthcare professionals and healthcare establishments by promoting the adoption of innovative healthcare solutions. Presentation.

In the spirit of the Health Innovation – Health Crisis Coalition, which has met with great success with the reception of more than 400 projects and the deployment of 17 structuring projects in 40 health establishments with 60,000 patients, “Coalition Next” intends to draw inspiration for 2021 from this particularly efficient and agile model. Calls for projects will be launched to meet unmet public health needs for all pathologies – chronic or acute – and at the service of all players in the health world: patients, health professionals, healthcare establishments and associations. patients.

The Health Innovation – Health Crisis Coalition saw the birth of a new very effective collaborative model, the challenge today is to be able to perpetuate this spirit through a new dynamic. “ Containment has been a real accelerator for e-health solutions which have taken an essential place in the care of patients and their remote monitoring. This is why it now seems opportune to us to take advantage of the experience and the unique partnership model of the Health Innovation Coalition under the aegis of Coalition Next. This alliance is open to all actors who could support this mission and participate in the collective effort in the service of patients, caregivers, caregivers and the health system ”explains Pascal Bécache, Co-Founder of Digital Pharma Lab and Operator of Coalition Next.

Today, “Coalition Next” aims to broaden the subjects of calls for projects in their transversality, to improve the quality of life of patients to better live their disease, their daily life with their treatments and to facilitate their care pathways. . The ambition of its members is to provide long-term technological and therapeutic solutions with high impact, accessible to a greater number of patients and their representatives from the associative world, to all city health professionals or care establishments. by relying on the innovative technologies of young companies.

“Coalition Next” is an initiative led by Digital Pharma Lab, the leading independent PharmaTech accelerator in Europe, in partnership with the pharmaceutical groups GSK, Ipsen, Mylan, a company of the Viatris group, Novartis, Pfizer, Roche, Takeda and, the structures of care provided by the AP-HP, the Nantes and Brest University hospitals, Vivalto health and patient associations with the Association Étincelle, as well as innovation players such as France Digitale and France Biotech, which chairs the Ethics Committee .

Coalition Next has an operating charter bringing together the founding members who belong to public or private structures. The first members to join the initiative are composed of pharmaceutical laboratories GSK, Ipsen, Mylan, a company of the Viatris group, Novartis, Pfizer, Roche, Takeda, healthcare and research structures such as Assistance Publique-Hôpitaux de Paris. (AP-HP), the Nantes and Brest University hospitals and Vivalto health and as well as patient associations such as the Association Étincelle or even innovation players such as France Biotech and France Digitale.

The presidency of the Founders Committee will be rotated between the founding members. It is currently insured, and for the next six months, by Amandine Jacques, Customer Excellence Head at Takeda. An ethics committee has also been created to guarantee transparent and ethical functioning between all “Coalition Next” members. It will be chaired by Franck Mouthon, President of France Biotech.

” This original initiative places the patient at the heart of the identification of innovative solutions. All our teams are mobilized and impatient at the idea of ​​working together, with a large number of health actors, and launching calls for projects on several themes.. »Continues Amandine Jacques, President of the Founders Committee.

“ The mission of the ethics committee is to inform the coalition on the issues of responsibility and reputation and also to ensure the role of independent trusted third party for entrepreneurs, the ecosystem of innovation in health and health authorities. . It is made up of a multidisciplinary team with Myriam Oukkal, President of the e-Health Committee, Chahra Louafi, Director of the Autonomous Patient Fund at Bpifrance and Maryne Cotty-Esclous, President of Lucine and expert in Dtx ” continues Franck Mouthon, Chairman of the Ethics Committee.

“ We are very happy to be able to count on the “ Coalition Next »Who will support us so that women suffering from breast cancer and in particular from metastatic cancers, can maintain a good quality of life while following their treatments which are often very heavy ” continues Evelyne Strechinsky, President of the Association Étincelle and Founding Member Coalition Next.

For Tara Duong, Head of the Transfer and Innovation Pole of the Clinical Research and Innovation Department (DRCI) of the AP-HP ” We are very happy to participate in “ Coalition Next “. We believe it is very important that AP-HP, which is a major player in clinical research, be associated with the process by contributing to collective reflection and ultimately benefit from the innovations that will be supported. ”.

Launch of the first calls for projects

Coalition Next’s mission is to launch calls for projects on specific themes in order to promote the adoption of e-health solutions for all patients. These solutions meet needs previously expressed by healthcare professionals and healthcare establishments.

The members of Coalition Next have identified several themes that will be the subject of AAP such as improving screening, delay in diagnosis and patient management as well as optimizing the care pathway and digitizing trials. clinics.

The forms of funding available for projects elected by the Coalition have been broadened. Indeed, Digital Pharma Lab, operator of “Coalition Next”, has decided to go further by creating a new financing tool called “PharmaTechVenture ”, which should be endowed with 2 million euros.

The first calls for projects are available today on the Coalition Next platform: www.coalitionnext.com

Source: Coalition Next

Similar articles

[ad_2]